Clinical trials are essential in developing new, improved, and more effective treatments and interventions. Without trials, researchers and professionals in the field cannot properly determine whether these new treatments and interventions are safe and effective.
Furthermore, when larger group testing occurs, this allows researchers to identify and ensure that any improvements resulting from the intervention occurs for as many people as possible and are not just occurring in one individual.
Ahead of the J.P. Morgan Health Conference in San Francisco in January 2023, Australian Health Journal met with Clinials CEO & Founder Maree Beare about developing the next generation recruitment platform and digital marketing service for clinical research. Maree talks about the reasons why clinical trials can fail and the importance of bringing participants much more closer to researchers.
With this need, the Clinials platform is geared towards patient centric trials and reducing site burden. The aim is to accelerate lifesaving medicines coming to market by connecting participants and researchers. The platform allows participants to come to researchers with their eligibility in hand among other capabilities.
Supporting CRO’s, sites and sponsors, the Clinials platform uses AI to convert complex trial protocol into plain language and pre-screening questions. This gives researchers the tools to communicate with their participants meaningfully. The plain language text can be used in a variety of situations like researcher led advertising, landing pages and plain language summaries.
You Might also like
-
Spinal implant technology eyes global opportunity
Adelaide, South Australia wants to let the secret out, and be known as hub for medical devices, pharmaceuticals, biotechnology, and digital health. It boasts world-class research institutions, such as the University of Adelaide and SAHMRI, fostering innovation and collaboration. The city’s supportive government policies provide incentives, grants, and streamlined regulations for businesses. Adelaide’s skilled workforce, renowned for its expertise in health sciences, offers a talent pool to drive industry growth. Additionally, the city’s strategic location, advanced infrastructure, and strong healthcare ecosystem make it an ideal base for development, manufacturing, and market access, attracting companies in these sectors.
-
Study on digital tool for pharmacists in aged care
In March 2022, the Australia government announced $350 million of funding over 4 years to employ on-site pharmacists in residential aged care, starting July 2023. In April 2023, the government made changes to the proposed on-site pharmacists, where the new program will now be delivered by and through community pharmacies. Regardless of how the model will be implemented, the goal remains the same – to improve quality use of medicines and medicines safety for aged care residents.
-
Global GP Conference comes to Australia
Over 3000 delegates from around the World will gather at the 50th celebration of WONCA to reconnect and revive General Practice, sharing knowledge and learnings on access, equity, funding, and multidisciplinary care teams. This includes networking with Australian and overseas GPs and in particular learning about primary care practices in other countries.
Australian Health Journal met with Dr Nicole Higgins, President of RACGP in transit at Brisbane Airport recently and she spoke about the $6 Billion allocated in the Federal Budget in May as a significant achievement for General Practice investment. She also emphasised this announcement reinforced GPs should be at the centre of multidisciplinary care teams to ensure continuity of care and better health outcomes.